Dr Reddy's Laboratories EBIT 2010-2024 | RDY

Dr Reddy's Laboratories EBIT for the quarter ending September 30, 2024 was $0.209B, a 2.88% decline year-over-year.

  • Dr Reddy's Laboratories 2024 EBIT was 0.812B, a 16.83% increase from 2023.
  • Dr Reddy's Laboratories 2023 EBIT was 0.695B, a 78.66% increase from 2022.
  • Dr Reddy's Laboratories 2022 EBIT was 0.389B, a 13.36% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Dr Reddy's Laboratories EBIT 2010-2024 | RDY

  • Dr Reddy's Laboratories 2024 EBIT was 0.812B, a 16.83% increase from 2023.
  • Dr Reddy's Laboratories 2023 EBIT was 0.695B, a 78.66% increase from 2022.
  • Dr Reddy's Laboratories 2022 EBIT was 0.389B, a 13.36% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M